Ocriplasmin Research to Better Inform Treatment (ORBIT)

Completed

Conditions studied: Symptomatic Vitreomacular Adhesion

In brief

This is a multicenter, prospective, observational, Phase 4 study that will assess clinical outcomes and safety of JETREA® administered in a real-world setting for the treatment of symptomatic vitreomacular adhesion (VMA) by assessing anatomical and functional outcomes in 1500 patients recruited across approximately 120 USA retina sites.

Key facts

Study ID
NCT02079883
Run by
ThromboGenics
People needed
540
Starts
2014-05-01
Expected to finish
2016-05-01
Last updated by the study team
2016-06-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.